etidronate has been researched along with uranium in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braun, EM; Cabrini, RL; Ubios, AM | 1 |
| Ansoborlo, E; Chazel, V; Gourmelon, P; Henge-Napoli, MH; Houpert, P; Paquet, F | 1 |
| Cabrini, RL; MartÃnez, AB; Ubios, AM | 1 |
| Gerasimo, P; Hoffschir, D; Marty, JP; Tymen, H | 1 |
| Bozal, CB; Cabrini, RL; Mandalunis, PM; Martinez, AB; Ubios, AM | 1 |
| Fukuda, S; Iida, H; Ikeda, M; Xie, Y; Yan, X | 1 |
| Fukuda, S | 1 |
| Fukuda, S; Ikeda, M; Nakamura, M; Xie, Y; Yan, X | 1 |
1 review(s) available for etidronate and uranium
| Article | Year |
|---|---|
Chelating agents used for plutonium and uranium removal in radiation emergency medicine.
Topics: Animals; Aza Compounds; Catechols; Chelating Agents; Deferiprone; Diphosphonates; Emergency Medicine; Humans; Iron Chelating Agents; Pentetic Acid; Plutonium; Pyridones; Radiation Injuries; Uranium | 2005 |
7 other study(ies) available for etidronate and uranium
| Article | Year |
|---|---|
Lethality due to uranium poisoning is prevented by ethane-1-hydroxy-1,1-biphosphonate (EHBP).
Topics: Animals; Etidronic Acid; Poisoning; Rats; Rats, Wistar; Renal Insufficiency; Survival Rate; Uranium | 1994 |
Efficacy of ethane-1-hydroxy-1,1-bisphosphonate (EHBP) for the decorporation of uranium after intramuscular contamination in rats.
Topics: Animals; Antidotes; Bone and Bones; Chelating Agents; Disease Models, Animal; Etidronic Acid; Injections, Intramuscular; Injections, Intraperitoneal; Kidney; Male; Organ Specificity; Rats; Rats, Sprague-Dawley; Tissue Distribution; Uranium | 1999 |
Orally administered ethane-1-hydroxy-1,1-biphosphonate reduces the lethal effect of oral uranium poisoning.
Topics: Administration, Oral; Animals; Diphosphonates; Injections, Subcutaneous; Male; Mice; Mice, Inbred BALB C; Radiation Injuries, Experimental; Radiation-Protective Agents; Survival Rate; Uranium | 2000 |
[Efficiency of etidronic acid in the case of cutaneous radiocontamination by actinid elements: in vitro evaluation].
Topics: Chelating Agents; Decontamination; Etidronic Acid; Humans; Organ Culture Techniques; Pentetic Acid; Plutonium; Skin; Uranium | 2000 |
Renal function in mice poisoned with oral uranium and treated with ethane-1-hydroxy-1,1-bisphosphonate (EHBP).
Topics: Administration, Cutaneous; Administration, Oral; Animals; Creatinine; Diphosphonates; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred BALB C; Radiation Tolerance; Radiation-Protective Agents; Uranium; Urea | 2003 |
Toxicity of uranium and the removal effects of CBMIDA and EHBP in simulated wounds of rats.
Topics: Animals; Catechols; Chelating Agents; Chelation Therapy; Diphosphonates; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Foreign Bodies; Injections, Intramuscular; Men; Metabolic Clearance Rate; Organ Specificity; Radiation Injuries; Radiation Protection; Rats; Rats, Wistar; Survival; Tissue Distribution; Treatment Outcome; Uranium; Wounds, Penetrating | 2005 |
Effects of pH on du intake and removal by CBMIDA and EHBP.
Topics: Animals; Catechols; Chelating Agents; Diphosphonates; Dose-Response Relationship, Radiation; Feces; Hydrogen-Ion Concentration; Injections, Intraperitoneal; Male; Metabolic Clearance Rate; Organ Specificity; Radiation-Protective Agents; Rats; Rats, Wistar; Tissue Distribution; Uranium | 2007 |